Pure Biologics (WAR:PUR) Pretax Margin %: % (As of Mar. 2026)


WAR:PUR Pure Biologics SA WAR:PUR
19 GF Score
Price zł2.12
! 2 Warning Signs
View Full Analysis

What is Pure Biologics Pretax Margin %?

Pure Biologics WAR:PUR -2.08% 19 Pretax Margin % is % as of Mar. 2026. GuruFocus rates WAR:PUR with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 941 Biotechnology companies, Pure Biologics ranks worse than 106269.82% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pure Biologics's Pre-Tax Income for the three months ended in Mar. 2026 was zł-2.36 Mil. Pure Biologics's Revenue for the three months ended in Mar. 2026 was zł0.00 Mil. Therefore, Pure Biologics's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for Pure Biologics's Pretax Margin % or its related term are showing as below:


WAR:PUR's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.37
* Ranked among companies with meaningful Pretax Margin % only.

Pure Biologics  (WAR:PUR) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Pure Biologics Pretax Margin % Related Terms


Pure Biologics Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Pure Biologics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pure Biologics Pretax Margin % Chart

Pure Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4,631.89 -3,867.52 0.00 0.00 0.00

Pure Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

WAR:PUR vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Pure Biologics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Biologics Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pure Biologics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Pure Biologics's Pretax Margin % falls into.


WAR:PUR
19GF Score
Pure Biologics SA WAR:PUR
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pure Biologics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Pure Biologics's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-7.835/0
= %

Pure Biologics's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.361/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Pure Biologics (WAR:PUR) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pure Biologics and its competitors. According to the industry distribution chart, Pure Biologics ranks #999999 out of 941 companies in the Biotechnology industry.
Is Pure Biologics' Pretax Margin % too high?
Pure Biologics' current Pretax Margin % is %. Based on the distribution chart, Pure Biologics ranks #999999 out of 941 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pure Biologics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pure Biologics' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pure Biologics ranks #999999 out of 941 companies for Pretax Margin %. This places Pure Biologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pure Biologics and its competitors. Pure Biologics's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pure Biologics stock overvalued right now?
Pure Biologics (WAR:PUR) has a current Pretax Margin % of %. The current Pretax Margin % is %. Pure Biologics' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pure Biologics (WAR:PUR), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pure Biologics Business Description

Address ul. Dunska 11, Wroclaw, POL, 54-427
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
19GF Score

Get the complete analysis for WAR:PUR

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.12
Price